Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid in capital
Accumulated deficit
Preferred A Shares (pre-merger-BiomX Ltd.)
Preferred B Shares (pre-merger-BiomX Ltd.)
Total
Balance at Dec. 31, 2018 [1] $ 64,410 $ (21,609) $ 1 $ 1 $ 42,803
Balance, shares at Dec. 31, 2018 [2] 2,307,871     7,543,831 5,170,357  
Issuance of shares [2] 1,800 [1] 1,800
Issuance of shares, shares [2]     308,628  
Share-based payment 304 304
Net loss (3,225) (3,225)
Balance at Mar. 31, 2019 [1] 66,514 (24,834) $ 1 $ 1 41,682
Balance, shares at Mar. 31, 2019 [2] 2,307,871     7,543,831 5,478,985  
Share-based payment   327       327
Net loss     (3,778)     (3,778)
Balance at Jun. 30, 2019 [1] 66,841 (28,612) $ 1 $ 1 38,231
Balance, shares at Jun. 30, 2019 [2] 2,307,871     7,543,831 5,478,985  
Exercise of options [1] 43 43
Exercise of options, shares [2] 41,200      
Share-based payment 249 249
Net loss (4,260) (4,260)
Balance at Sep. 30, 2019 [1] 67,133 (32,872) $ 1 $ 1 34,263
Balance, shares at Sep. 30, 2019 [2] 2,349,071     7,543,831 5,478,985  
Balance at Dec. 31, 2019 $ 2 126,626 (42,172)     84,456
Balance, shares at Dec. 31, 2019 22,862,835          
Exercise of options [1] 106     106
Exercise of options, shares 57,325          
Share-based payment   337     337
Net loss   (5,901)     (5,901)
Balance at Mar. 31, 2020 $ 2 127,069 (48,073)     78,998
Balance, shares at Mar. 31, 2020 22,920,160          
Exercise of options [1] 52     52
Exercise of options, shares 220,104          
Share-based payment   677       677
Net loss     (6,206)     (6,206)
Balance at Jun. 30, 2020 $ 2 127,798 (54,279)     73,521
Balance, shares at Jun. 30, 2020 23,140,264          
Exercise of options 38     38
Exercise of options, shares 27,414          
Share-based payment   1,114     1,114
Net loss   (8,835)     (8,835)
Balance at Sep. 30, 2020 $ 2 $ 128,950 $ (63,114)     $ 65,838
Balance, shares at Sep. 30, 2020 23,167,678          
[1] Less than $1.
[2] Number of shares has been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction consummated on October 28, 2019 (refer to Note 1).